Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study

被引:27
|
作者
Gravina, Antonietta Gerarda [1 ]
Pellegrino, Raffaele [1 ]
Durante, Tommaso [2 ]
Palladino, Giovanna [1 ]
D'Onofrio, Rossella [1 ]
Mammone, Simone [1 ]
Arboretto, Giusi [1 ]
Auletta, Salvatore [1 ]
Imperio, Giuseppe [1 ]
Ventura, Andrea [1 ]
Romeo, Mario [1 ]
Federico, Alessandro [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Precis Med, Hepatogastroenterol Unit, Via L de Crecchio, I-80138 Naples, Italy
[2] S Pio Hosp, Mental Hlth Dept, I-82100 Benevento, Italy
关键词
Crohn's disease; Inflammatory bowel disease; International Physical Activity Questionnaire; Physical activity; Ulcerative colitis; QUALITY-OF-LIFE; REPORTED OUTCOME MEASURES; EXERCISE; RELIABILITY; SARCOPENIA; PEOPLE;
D O I
10.3748/wjg.v29.i41.5668
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDThe place regular physical activity (PA) should occupy in managing patients with inflammatory bowel diseases (IBD) is unclear.AIMTo assess PA levels and barriers in a southern Italian IBD population.METHODSIBD patients with non-severe disease activity [assessed with partial Mayo score for ulcerative colitis (UC) and Harvey-Bradshaw index for Crohn's disease] were approached to receive an anonymous online questionnaire to assess PA levels using the International Physical Activity Questionnaire (IPAQ) and to assess disease activity as patient-reported outcomes 2 (PRO-2) and finally to assess habits, beliefs and barriers in conducting regular PA. Clinical, anthropometric and demographic data of patients were also collected. PA was expressed as continuous units of resting metabolic rate (Met) in min/wk. Three PA groups were identified: Inactive (< 700 Met min/wk), sufficiently active (700-2500 Met min/wk) and health enhancing PA (HEPA) (i.e., HEPA active, > 2500 Met min/wk) patients.RESULTSIncluded patients (219) showed overall PA levels of 834.5 Met min/wk, with a large proportion (94, 42.9%) classified as inactive while only a minority (9, 4.1%) as health-enhancing PA. Patients without dyslipidaemia (P < 0.0001) or on biologics therapy (P = 0.022) showed better IPAQ scores in moderate activities. UC PRO-2 correlated negatively with IPAQ intense activities scores (tau = -0.156, P = 0.038). PRO-2 did not show notable sensitivity/specificity in predicting IPAQ inactivity (AUC < 0.6). IBD activity did not differ between active and inactive patients (P > 0.05). Active patients expressed the need to discuss PA with their gastroenterologist. Some barriers (e.g., diagnosis of IBD and fear of flare-ups after PA) are significantly more reported by inactive patients.CONCLUSIONA significant rate of physical inactivity was recorded in this setting. IPAQ showed good feasibility. PA should be an element of discussion in IBD visits assessed quickly with non-invasive questionnaires.
引用
收藏
页码:5668 / 5682
页数:15
相关论文
共 50 条
  • [21] Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group
    de Ridder, Lissy
    Turner, Dan
    Wilson, David C.
    Koletzko, Sibylle
    Martin-de-Carpi, Javier
    Fagerberg, Ulrika L.
    Spray, Christine
    Sladek, Malgorzata
    Shaoul, Ron
    Roma-Giannikou, Eleftheria
    Bronsky, Jiri
    Serban, Daniela E.
    Cucchiara, Salvatore
    Veres, Gabor
    Ruemmele, Frank M.
    Hojsak, Iva
    Kolho, Kaija L.
    Davies, Ieuan H.
    Aloi, Marina
    Lionetti, Paolo
    Veereman-Wauters, Gigi
    Braegger, Christian P.
    Trindade, Eunice
    Wewer, Anne V.
    Hauer, Almuthe
    Levine, Arie
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (02) : 291 - 300
  • [22] Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD
    Vieujean, Sophie
    Lindsay, James O.
    D'Amico, Ferdinando
    Ahuja, Vineet
    Silverberg, Mark S.
    Sood, Ajit
    Yamamoto-Furusho, Jesus K.
    Nagahori, Masakazu
    Watanabe, Mamoru
    Koutroubakis, Ioannis E.
    Foteinogiannopoulou, Kalliopi
    Avni Biron, Irit
    Walsh, Alissa
    Outtier, An
    Nordestgaard, Rie Louise Moller
    Abreu, Maria T.
    Dubinsky, Marla
    Siegel, Corey
    Louis, Edouard
    Dotan, Iris
    Reinisch, Walter
    Danese, Silvio
    Rubin, David T.
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (04) : 548 - 559
  • [23] Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center
    Szanto, Kata
    Nyari, Tibor
    Balint, Anita
    Bor, Renate
    Milassin, Agnes
    Rutka, Mariann
    Fabian, Anna
    Szepes, Zoltan
    Nagy, Ferenc
    Molnar, Tamas
    Farkas, Klaudia
    PLOS ONE, 2018, 13 (07):
  • [24] Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study
    Vernero, Marta
    Saibeni, Simone
    Scalvini, Davide
    Cicalini, Carolina
    Chiarello, Lorenzo
    Nardi, Silvia
    Ribaldone, Davide Giuseppe
    Bezzio, Cristina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [25] Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
    Buisson, Anthony
    Nachury, Maria
    Reymond, Maud
    Yzet, Clara
    Wils, Pauline
    Payen, Laure
    Laugie, Marie
    Manlay, Luc
    Mathieu, Nicolas
    Pereira, Bruno
    Fumery, Mathurin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2338 - 2346
  • [26] Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study
    Marin-Jimenez, Ignacio
    Garcia Sanchez, Valle
    Gisbert, Javier P.
    Perez Calle, Jose Lazaro
    Lujan, Marisol
    Gordillo Abalos, Jordi
    Tabernero, Susana
    Julia, Berta
    Romero, Cristina
    Cea-Calvo, Luis
    Garcia-Vicuna, Rosario
    Vanaclocha, Francisco
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2014, 37 (09): : 495 - 502
  • [27] A cross-sectional study exploring levels of physical activity and motivators and barriers towards physical activity in haemodialysis patients to inform intervention development
    Sutherland, Sheera
    Penfold, Rose
    Doherty, Aiden
    Milne, Zara
    Dawes, Helen
    Pugh, Christopher
    Boulton, Mary
    Newton, Julia L.
    DISABILITY AND REHABILITATION, 2021, 43 (12) : 1675 - 1681
  • [28] Treatment regimens and disease activity could alter salivary myeloperoxidase levels in patients with inflammatory bowel diseases
    Nijakowski, Kacper
    Motylewska, Barbara
    Banasik, Estera
    Rutkowski, Rafal
    Tsaryk, Vasili
    Luczak, Joanna
    Korybalska, Katarzyna
    Witowski, Janusz
    Surdacka, Anna
    Eder, Piotr
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2024, 134 (01):
  • [29] Dietary risk factors for inflammatory bowel diseases in a high-risk population: Results from the Faroese IBD study
    Hammer, T.
    Lophaven, S. Nymand
    Nielsen, K. Rubek
    Petersen, M. Skaalum
    Munkholm, P.
    Weihe, P.
    Burisch, J.
    Lynge, E.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (07) : 924 - 932
  • [30] Prevalence of physical activity levels and perceived benefits of and barriers to physical activity among Jordanian patients with coronary heart disease: A cross-sectional study
    Alsaleh, Eman
    Baniyasin, Faris
    FRONTIERS IN PUBLIC HEALTH, 2023, 10